{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:41:22Z","timestamp":1652010082802},"reference-count":0,"publisher":"Hogrefe Publishing Group","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutische Umschau"],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:p> Neben den selektiven parenteralen Anti Faktor Xa-Pr\u00e4paraten Fondaparinux und Idraparinux, sind die oralen Anti Faktor Xa-Pr\u00e4parate Apixaban (Eliquis\u00ae) und Rivaroxaban (Xarelto\u00ae) gut untersucht in der Pr\u00e4vention der ven\u00f6sen Thromboembolie nach orthop\u00e4dischen Eingriffen, bei der Pr\u00e4vention von Schlaganf\u00e4llen bei Vorhofflimmern und bei der Therapie der ven\u00f6sen Thromboembolie. In der Folge werden die Indikationen, Kontraindikationen, Limitationen und der zugelassene Einsatz der Pr\u00e4parate aufgezeigt. <\/jats:p>","DOI":"10.1024\/0040-5930\/a000341","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T02:17:34Z","timestamp":1359771454000},"page":"635-641","source":"Crossref","is-referenced-by-count":0,"title":["Neue Antikoagulantien - die Anti-Faktor Xa-Antagonisten"],"prefix":"10.1024","volume":"69","author":[{"family":"B\u00e4chli","sequence":"first","affiliation":[{"name":"Medizinsche Klinik, Spital Uster"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","container-title":["Therapeutische Umschau"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0040-5930\/a000341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T11:00:28Z","timestamp":1652007628000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0040-5930\/a000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11,1]]}},"alternative-id":["10.1024\/0040-5930\/a000341"],"URL":"https:\/\/doi.org\/10.1024\/0040-5930\/a000341","relation":{},"ISSN":["0040-5930","1664-2864"],"issn-type":[{"value":"0040-5930","type":"print"},{"value":"1664-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}